We could not find any results for:
Make sure your spelling is correct or try broadening your search.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pip... DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1. Show more
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company currently focused on developing recombinant KLK1 (DM199) for the treatment of acute ischemic stroke...
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardio-renal disease, today announced...
Conference Call and Webcast March 20 at 8:00 AM Eastern Time / 7:00 AM Central Time ReMEDy2 Clinical Site Activation Commenced in December 2023 Strengthened Management Team with Lorianne Masuoka...
DiaMedica Presents the Protocol and Rationale for ReMEDy2, a Pivotal Trial in Patients Suffering Acute Ischemic Stroke Ineligible for tPA and/or Mechanical Thrombectomy DiaMedica Therapeutics...
Executive with Strong Track Record in Advancing Pipelines Through Clinical Development DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.31 | 12.3505976096 | 2.51 | 2.95 | 2.4943 | 16291 | 2.5933531 | CS |
4 | -0.05 | -1.74216027875 | 2.87 | 3.2 | 2.26 | 33475 | 2.63859894 | CS |
12 | -0.41 | -12.693498452 | 3.23 | 3.34 | 2.26 | 36368 | 2.81304504 | CS |
26 | 0.22 | 8.46153846154 | 2.6 | 3.34 | 2.12 | 43341 | 2.75150762 | CS |
52 | 1.19 | 73.0061349693 | 1.63 | 4.75 | 1.58 | 78956 | 3.12530479 | CS |
156 | -6.69 | -70.3470031546 | 9.51 | 9.84 | 1.12 | 108735 | 3.4035005 | CS |
260 | -0.55 | -16.3204747774 | 3.37 | 10.88 | 1.12 | 101038 | 4.37629276 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions